Colorectal
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Folate and folic acid intake in relation to molecular subtypes of colorectal cancer: pooled analyses of up to 8970 cases and 8098 control participants.
Clinical takeawayNo clinical action yet: pooled observational data from case-control and cohort studies, with intake from food frequency questionnaires or diet histories; the study does not test giving folate or folic acid.
What it foundTotal folate intake and folate supplement use were inversely associated with colorectal cancer risk, with a stronger inverse association for CIMP-low/negative vs. CIMP-high tumors (pdifference=0.07). Dietary folate showed a weaker association, and there was a null association for the Jass Type 2 subtype.
ContextHigher folate intake has been associated with modest reductions in colorectal cancer risk; across 8970 cases and 8098 controls, the authors judge the putative protective effect broad, not limited to BRAF, KRAS, MSI or CIMP subtypes.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Van Guelpen B … Peters U · American Journal of Clinical Nutrition · IF 6.5 · PubMed ↗